Nkgen Biotech, Common Stock Market Value
| NKGN Stock | 0.05 0 1.96% |
| Symbol | NKGen |
NKGen Biotech, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NKGen Biotech,'s pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NKGen Biotech,.
| 06/28/2025 |
| 12/25/2025 |
If you would invest 0.00 in NKGen Biotech, on June 28, 2025 and sell it all today you would earn a total of 0.00 from holding NKGen Biotech, Common or generate 0.0% return on investment in NKGen Biotech, over 180 days. NKGen Biotech, is related to or competes with Prenetics Global, Nuwellis, P3 Health, Dermata Therapeutics, Aclarion, and Purple Biotech. More
NKGen Biotech, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NKGen Biotech,'s pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NKGen Biotech, Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 46.02 | |||
| Information Ratio | 0.2302 | |||
| Maximum Drawdown | 445.0 | |||
| Value At Risk | (21.28) | |||
| Potential Upside | 100.0 |
NKGen Biotech, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NKGen Biotech,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NKGen Biotech,'s standard deviation. In reality, there are many statistical measures that can use NKGen Biotech, historical prices to predict the future NKGen Biotech,'s volatility.| Risk Adjusted Performance | 0.1721 | |||
| Jensen Alpha | 13.28 | |||
| Total Risk Alpha | 8.87 | |||
| Sortino Ratio | 0.2997 | |||
| Treynor Ratio | 1.42 |
NKGen Biotech, Common Backtested Returns
NKGen Biotech, is out of control given 3 months investment horizon. NKGen Biotech, Common has Sharpe Ratio of 0.24, which conveys that the firm had a 0.24 % return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 14.76% are justified by taking the suggested risk. Use NKGen Biotech, Common mean deviation of 30.24, and Risk Adjusted Performance of 0.1721 to evaluate company specific risk that cannot be diversified away. NKGen Biotech, holds a performance score of 19 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 9.77, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, NKGen Biotech, will likely underperform. Use NKGen Biotech, Common total risk alpha and the relationship between the potential upside and price action indicator , to analyze future returns on NKGen Biotech, Common.
Auto-correlation | 0.18 |
Very weak predictability
NKGen Biotech, Common has very weak predictability. Overlapping area represents the amount of predictability between NKGen Biotech, time series from 28th of June 2025 to 26th of September 2025 and 26th of September 2025 to 25th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NKGen Biotech, Common price movement. The serial correlation of 0.18 indicates that over 18.0% of current NKGen Biotech, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.18 | |
| Spearman Rank Test | -0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
NKGen Biotech, Common lagged returns against current returns
Autocorrelation, which is NKGen Biotech, pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NKGen Biotech,'s pink sheet expected returns. We can calculate the autocorrelation of NKGen Biotech, returns to help us make a trade decision. For example, suppose you find that NKGen Biotech, has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NKGen Biotech, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NKGen Biotech, pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NKGen Biotech, pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NKGen Biotech, pink sheet over time.
Current vs Lagged Prices |
| Timeline |
NKGen Biotech, Lagged Returns
When evaluating NKGen Biotech,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NKGen Biotech, pink sheet have on its future price. NKGen Biotech, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NKGen Biotech, autocorrelation shows the relationship between NKGen Biotech, pink sheet current value and its past values and can show if there is a momentum factor associated with investing in NKGen Biotech, Common.
Regressed Prices |
| Timeline |
Pair Trading with NKGen Biotech,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NKGen Biotech, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NKGen Biotech, will appreciate offsetting losses from the drop in the long position's value.Moving against NKGen Pink Sheet
| 0.8 | SMGKF | Smiths Group plc | PairCorr |
| 0.65 | STAG | STAG Industrial | PairCorr |
| 0.53 | ARRXF | Archer Materials | PairCorr |
| 0.41 | BCAB | Bioatla | PairCorr |
| 0.4 | SHG | Shinhan Financial | PairCorr |
The ability to find closely correlated positions to NKGen Biotech, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NKGen Biotech, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NKGen Biotech, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NKGen Biotech, Common to buy it.
The correlation of NKGen Biotech, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NKGen Biotech, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NKGen Biotech, Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NKGen Biotech, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in NKGen Pink Sheet
NKGen Biotech, financial ratios help investors to determine whether NKGen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NKGen with respect to the benefits of owning NKGen Biotech, security.